MTAP and melanocytic neoplasm: In this dual-marker paradigm, MTAP not only refines the classification of diagnostically ambiguous melanocytic neoplasms but may also hold therapeutic implications, identifying tumors potentially susceptible to PRMT5 and related methyltransferase inhibitors in the context of 9p21 codeletion.